Jump to Content Jump to Main Navigation

Volume 24 (2017): Issue 8 (Aug 2017)

in Endocrine-Related Cancer

Online ISSN:: 1479-6821

Print ISSN:: 1351-0088

Contents

Review
- Rationale for the development of alternative forms of androgen deprivation therapy
  
  Author(s): Sangeeta Kumari, Dhirodatta Senapati and Hannelore V Heemers
  
  Pages: R275–R295
- Estradiol for the mitigation of adverse effects of androgen deprivation therapy
  
  Author(s): Nicholas Russell, Ada Cheung and Mathis Grossmann
  
  Pages: R297–R313
Research
- Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease
  
  Author(s): Laura C Hernández-Ramírez, Ryhem Gam, Nuria Valdés, Maya B Lodish, Nathan Pankratz, Aurelio Balsalobre, Yves Gauthier, Fabio R Faucz, Giampaolo Trivellin, Prashant Chittiboina, John Lane, Denise M Kay, Aggeliki Dimopoulos, Stephan Gaillard, Mario Neou, Jérôme Bertherat, Guillaume Assié, Chiara Villa, James L Mills, Jacques Drouin and Constantine A Stratakis
  
  Pages: 379–392
  
  Editor's Choice
- Testicular vs adrenal sources of hydroxy-androgens in prostate cancer
  
  Author(s): Tianzhu Zang, Mary-Ellen Taplin, Daniel Tamae, Wanling Xie, Clementina Mesaros, Zhenwei Zhang, Glenn Bubley, Bruce Montgomery, Steven P Balk, Elahe A Mostaghel, Ian A Blair and Trevor M Penning
  
  Pages: 393–404
- Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms
  
  Author(s): Roberto Valente, Alastair J Hayes, Sven-Petter Haugvik, Per Hedenström, Darko Siuka, Emilie Korsæth, Daniel Kämmerer, Stuart M Robinson, Patrick Maisonneuve, Gianfranco Delle Fave, Bjorn Lindkvist and Gabriele Capurso
  
  Pages: 405–414
- STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance
  
  Author(s): Praveena S Thiagarajan, Qiao Zheng, Manvir Bhagrath, Erin E Mulkearns-Hubert, Martin G Myers, Justin D Lathia and Ofer Reizes
  
  Pages: 415–426
- A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
  
  Author(s): Jan P Dumanski, Chiara Rasi, Peyman Björklund, Hanna Davies, Abir S Ali, Malin Grönberg, Staffan Welin, Halfdan Sorbye, Henning Grønbæk, Janet L Cunningham, Lars A Forsberg, Lars Lind, Erik Ingelsson, Peter Stålberg, Per Hellman and Eva Tiensuu Janson
  
  Pages: 427–443
- Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas
  
  Author(s): R Formosa, J Borg and J Vassallo
  
  Pages: 445–457
Research Letter
- SDHB mutation carriers with malignant pheochromocytoma respond better to CVD
  
  Author(s): L Fishbein, S Ben-Maimon, S Keefe, K Cengel, D A Pryma, A Loaiza-Bonilla, D L Fraker, K L Nathanson and D L Cohen
  
  Pages: L51–L55
- KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors
  
  Author(s): Lucie Evenepoel, Raphaël Helaers, Laurent Vroonen, Selda Aydin, Marc Hamoir, Dominique Maiter, Miikka Vikkula and Alexandre Persu
  
  Pages: L57–L61
- The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations
  
  Author(s): Frederic Castinetti, Ana Luiza Maia, Mariola Peczkowska, Marta Barontini, Kornelia Hasse-Lazar, Thera P Links, Rodrigo A Toledo, Sarka Dvorakova, Caterina Mian, Maria Joao Bugalho, Stefania Zovato, Maria Alevizaki, Andrei Kvachenyuk, Birke Bausch, Paola Loli, Simona R Bergmann, Attila Patocs, Marija Pfeifer, Josefina Biarnes Costa, Ernst von Dobschuetz, Claudio Letizia, Gerlof Valk, Marcin Barczynski, Malgorzata Czetwertynska, John T M Plukker, Paola Sartorato, Tomas Zelinka, Petr Vlcek, Svetlana Yaremchuk, Georges Weryha, Letizia Canu, Nelson Wohllk, Frederic Sebag, Martin K Walz, Charis Eng and Hartmut P H Neumann
  
  Pages: L63–L67
Letter to the Editor
- A case of a metastatic SDHA mutated paraganglioma re-presenting twenty-three years after initial surgery
  
  Author(s): Ruth T Casey, Benjamin G Challis, Alison Marker, Deborah Pitfield, Heok K Cheow, Ashley Shaw, Soo-Mi Park, Helen L Simpson and Eamonn R Maher
  
  Pages: L69–L71

Save
Email
Share
Share
Share

Top

Print ISSN:: 1351-0088

Online ISSN:: 1479-6821